Zijing Yang, Student Fellow, Stanford LLM 2025.
Chinaas national drug centralized procurement policy implemented since 2018 for off-patent drugs.
The Medical Insurance Negotiation leverages the expectation of access to a large patient population to encourage pharmaceutical companies to lower prices for their drug products.
There has been growing concern within the industry that the downward pricing pressure may discourage pharmaceutical companies from investing heavily in research and development.
A customized collection of grant news from foundations and the federal government from around the Web.
In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.